-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide:
Introduction: Introduction:In recent years, the competition in the global pharmaceutical industry has become increasingly fierce, the division of labor in the pharmaceutical industry chain has become increasingly refined, and the specialized outsourcing of the pharmaceutical industry has become an important strategic choice for
In recent years, the competition in the global pharmaceutical industry has become increasingly fierce, the division of labor in the pharmaceutical industry chain has become increasingly refined, and the specialized outsourcing of the pharmaceutical industry has become an important strategic choice for
With the continuous improvement of the specialization of pharmaceutical outsourcing service institutions, the content of pharmaceutical outsourcing services gradually covers all aspects
According to the content of the services provided, pharmaceutical outsourcing service agencies mainly include CRO, CMO, CDMO enterprises, etc
Part I CRO, CMO, CDMO Part I Part I CRO, CMO, CDMOCMOCDMO
CRO enterprise (contract customized R&D institution) refers to an institution that provides professional services for pharmaceutical companies and R&D institutions in the process of drug research and development through contract forms
CRO enterprise (contract customized R&D institution) refers to an institution that provides professional services for pharmaceutical companies and R&D institutions in the process of drug research and development through contract forms
Unlike CRO companies, CMO/CDMO companies primarily focus on drug manufacturing services
CDMO enterprises (contract custom R&D and production institutions) in addition to providing traditional CMO production services, more emphasis on the development and innovation
Part II Differences between the Three in Drug Design and R&DPart II Differences between the Three in Drug Design and R&DPart II Differences between the Three in Drug Design and R&D The Differences Between the Three in Drug Design and R&D
The third part is the comparison of CDMO companies in the field of design and research and development
Part III Comparison of CDMO Companies in the Field of Design and R&D Part III Comparison of CDMO Companies in the Field of Design and R&D
Part IV The R&D Process of the CDMO Business
Part IV R&D Processes for CDMO BusinessPart IV Part IV R&D Processes for CDMO Businesses
Part V: The Relationship Between CDMO Services and Products sold
Part V Relationship between CDMO Services and Products SoldPart V Part V Relationship between CDMO Services and Products SoldThe sale of goods is the final form of delivery of the company's CDMO service results
The sale of goods is the final form of delivery of the company's CDMO service results
First, CDMO services are the business processes
The main goal of the CDMO services provided by the company to customers is to successfully develop products
The main goal of the CDMO services provided by the company to customers is to successfully develop products
Second, CDMO services are necessary to meet customer customization needs
Second, CDMO services are necessary to meet customer customization needs
Unlike most general products that can be organized and implemented after obtaining an order, pharmaceutical customized products are special products
Unlike most general products that can be organized and implemented after obtaining an order, pharmaceutical customized products are special products
with a strong degree of professionalism and a high degree of customization.
In the process of carrying out custom research and development and custom production, the company must always be aware of the specific needs of customized customers, and determine the technical details
of the product through repeated technical exchanges.
The company's CDMO service process is the process of the company providing various services such as process development according to customer-specific needs
.
In order to meet the customized needs of different customers at different stages of the drug life cycle, companies need to provide personalized customized R&D and production services
.
According to the requirements of customized customers, based on a deep understanding of the process technology, the company develops and determines the appropriate synthesis path and conditions, and through targeted adjustment of key process parameters, to achieve accurate control of the key properties of the target compound to meet customer requirements for
customized products.
Therefore, pharmaceutical enterprise customers expect customized goods obtained through entrusted cooperation, which can only be realized through the detailed service process of CDMO, which is a necessary condition
for the formation of customized goods.
Third, the end customer participates in the CDMO services
provided by the company through cooperation procedures such as quality audit.
Third, the end customer participates in the CDMO services
provided by the company through cooperation procedures such as quality audit.
Due to the particularity of the pharmaceutical industry, the customized R&D and production of the pharmaceutical industry is quite different from
the ordinary contract entrustment.
The end customer entrusts the drug development and production process to the company to customize the development, and pays great attention to the safety, effectiveness and quality of the drug and its intermediates, and cannot make a comprehensive and effective judgment
on the drug production process based on the final delivered goods.
Due to the particularity of the pharmaceutical industry, the customized R&D and production of the pharmaceutical industry is quite different from
the ordinary contract entrustment.
The end customer entrusts the drug development and production process to the company to customize the development, and pays great attention to the safety, effectiveness and quality of the drug and its intermediates, and cannot make a comprehensive and effective judgment
on the drug production process based on the final delivered goods.
the ordinary contract entrustment.
The end customer entrusts the drug development and production process to the company to customize the development, and pays great attention to the safety, effectiveness and quality of the drug and its intermediates, and cannot make a comprehensive and effective judgment
on the drug production process based on the final delivered goods.
Therefore, in the daily CDMO cooperation, pharmaceutical enterprise customers often participate in the company's CDMO service process through qualified supplier qualification identification, regular or irregular quality audits, etc.
, and implement the requirements of drug registration related to safety, effectiveness and quality controllability into the whole process
of customized research and development and production.
Therefore, the CDMO service process is a key way for pharmaceutical companies to ensure that the pharmaceutical intermediates or API products that the company ultimately delivers meet their quality requirements in all aspects
.
Therefore, the CDMO service process is a key way for pharmaceutical companies to ensure that the pharmaceutical intermediates or API products that the company ultimately delivers meet their quality requirements in all aspects
.
.
Fourth, the company's CDMO service content and delivery form are basically the
same as the CDMO service content and delivery form of comparable listed companies in the same industry.
Fourth, the company's CDMO service content and delivery form are basically the
same as the CDMO service content and delivery form of comparable listed companies in the same industry.
same as the CDMO service content and delivery form of comparable listed companies in the same industry.
Fourth, the company's CDMO service content and delivery form are basically the
same as the CDMO service content and delivery form of comparable listed companies in the same industry.
In summary, the sale of goods is the final delivery form of the company's CDMO service results, and cdmo services are the business process
of the formation of final goods.
CDMO service process is the only way for the final product formation, which is mainly reflected in the following two aspects: on the one hand, the products delivered by the company to customers are customized products, and the customized R&D and production needs of pharmaceutical companies can only be met through the detailed service process of CDMO; The CDMO service process, on the other hand, is a key way for pharmaceutical corporate customers to ensure that the pharmaceutical intermediates or API products that the company ultimately delivers meet their pharmaceutical requirements in all aspects
.
In addition, the company's CDMO service process and delivery form are basically consistent with the same industry, in line with industry practices
.
of the formation of final goods.
CDMO service process is the only way for the final product formation, which is mainly reflected in the following two aspects: on the one hand, the products delivered by the company to customers are customized products, and the customized R&D and production needs of pharmaceutical companies can only be met through the detailed service process of CDMO; The CDMO service process, on the other hand, is a key way for pharmaceutical corporate customers to ensure that the pharmaceutical intermediates or API products that the company ultimately delivers meet their pharmaceutical requirements in all aspects
.
In addition, the company's CDMO service process and delivery form are basically consistent with the same industry, in line with industry practices
.